Synthesis and diuretic properties of new 5-(4-pyrazolyl)-1,2,4-triazole and 3-(4-pyrazolyl)-1,2,4- triazolo[3,4-с][1,4]- oxazine derivatives

  • N.V. Panasenko -
  • M.K. Bratenko -
  • M.V. Vovk -
Keywords: 5-(4-pyrazolyl)-1,2,4-triazoles, 3-(4-pyrazolyl)-1,2,4-triazolo[3,4-с][1,4]-oxazines, diuretic activity

Abstract

New 5-(4-pyrazolyl)-1,2,4-triazoles and 3-(4-pyrazolyl)-1,2,4-triazolo[3,4-с][1,4]-oxazines were  synthesized  and have been established that obtaining compounds possess high diuretic activity.

References

1. Berkhin E. B. Methods of study of the action of new chemical compounds on the function of the kidneys // Chemistry. farm journ - 1977. - T. 11. No. 5. - P. 3-11.
2. Vovk MV, Bratenko M.K., Chornous VO 4-Functionally substituted pyrazoles. Chernivtsi: Prut. 2008 - 285 pp.
3. Gotsulya A.С. Diuretic activity of 4- (2-methoxyphenyl) -5-alkyl (aryl) -1,2,4-triazole-3-thione and their S-derivatives / OI Panasenko, Ye.G.Knish // Zaporozhye Medical Journal . - 2009. - T.11. - №4. - P.75-76.
4. Kaplaushenko AG Structure and diuretic activity of amino and thio derivatives of 1,2,4-triazole // Medical Chemistry. - 2007. - T.9. - №3. - P. 65-69.
5. Kaplaushenko AG Diuretic activity of 5-R-4-R1-1,2,4-triazole-3-thione and their S-derivatives / A. G. Kaplaushenko O.I. Panasenko, Ye.G. Knysh, O.O. Swintzelsky // Pharmaceutical Journal. - 2008. № 4. - P. 57-63.
6. Mashkovsky M.D. Medicines. Manual for doctors. In two volumes. T.1.Izd-13th, new. - Kharkov: "Torsing", 1998 - 487 p.
7. Mashkovsky M. D. Medicines. Manual for doctors. In two volumes. T. 1. Izd. 13th, new. - Kharkov, "Torsing". - 1998. -. 483 с.
8. Salyendo G., Grieco P., Perrisutti E., Santagada V., Antonello S., Albrizio S., Fattorus C., Pinto A., Sorrentino R. Synthesis, biological activity and conformational study of 1,4-benzoxazine derivatives as potassium chanal modulators // Eur. J. Med. Chem - 1998. - Vol. 33, No. 12.- P. 957-967.
9. Randomized, double-blind trial evaluation therapy in the mild to moderate assential hypertension in north-east China / S.Zhang, B.Yu, L.L. et al // J. Int. Med. Res - 2008. - Vol. 36. - No. 4. - P. 630-637.
10. Savelon L., Bizot-Espiard JB, Caidnard DH, Pfeiffer B., Renard R., Viaud MC, Guillaumet G. Substituted pyrido [3,2-b] oxazin-3 (4H) -one: synthesis and evaluation of antinociceptive activity // Bioorg. Med. Chem 1998.- Vol. 6, No. 2.- R. 133-142.
11. The efficacy and safety of the initial use of the irbesartan / hydrochlorothiazide fixed-dose combination in hypertensive patients with and without high cardiovascular risk / M.R.Weir, J.M.Neutel, A..Bhaumik et al. // J. Clin. Hypertens - 2007 - Vol. 9. - №12. - P. 23-30.
12. White W.B., Cleveland J. M., Roller R.L. Utility of semiautomatic clinic and 24-h ambulatory blood pressure measurements to evaluate combination therapy: Ramipril-Hydrochlorothiazide Hypertension trial // J. Hum. Hypertens - 2008. - Vol. 22. - №8. - P. 559-568
Published
2019-03-18
How to Cite
Panasenko, N., Bratenko, M., & Vovk, M. (2019). Synthesis and diuretic properties of new 5-(4-pyrazolyl)-1,2,4-triazole and 3-(4-pyrazolyl)-1,2,4- triazolo[3,4-с][1,4]- oxazine derivatives. Farmatsevtychnyi Zhurnal, (6), 86-92. Retrieved from https://pharmj.org.ua/index.php/journal/article/view/453
Section
Original Articles